Edwards Lifesciences Corporation
EWLast close · Oct 16, 202686.60−1.50 (−1.70%)
Market cap$49.9B
Of the 85 managers this site tracks, 3 held Edwards Lifesciences (EW) at the end of Q2 2026, their latest 13Fs. The largest position by value was Bridgewater's, $24.9M; David Rolfe's ($14.9M) and Torray's ($270,837) follow. No Schedule 13D or 13G is on file for EW from the activists and large holders the site follows.
Superinvestors holding EW
| Manager | Firm | Quarter | Shares | Value |
|---|---|---|---|---|
| Bridgewater | Bridgewater Associates, LP | Q2 2026 | 275,279 | $24.9M |
| David Rolfe | Wedgewood Partners Inc | Q2 2026 | 165,208 | $14.9M |
| Torray | Torray Investment Partners LLC | Q2 2026 | 2,994 | $270,837 |
13D/13G are SEC beneficial-ownership disclosures, triggered only above 5%; a 13F is a quarterly snapshot filed up to 45 days after quarter end. Superinvestor names link to their full portfolios under Investors.